NeuroPace Gets FDA Premarket Approval for the RNS System to Treat Medically Refractory Epilepsy

NeuroPace, Inc. announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.

http://www.hispanicbusiness.com/2013/11/26/neuropace_gets_fda_premarket_approval_for.htm